"Illinois Bone & Joint Institute provides comprehensive orthopedic care for adults and children at more than 50 locations in Illinois, including immediate care, physical therapy, imaging, workers' compensation and more."

During the past decade, Illinois Bone & Joint Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 10 clinical trials were completed, i.e. on average, 333.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois Bone & Joint Institute" #1 sponsor was "Pfizer" with 5 trials, followed by "Astellas Pharma Inc" with 2 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Medtronic Spinal and Biologics" with 2 trials sponsored and "Merrimack Pharmaceuticals" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Bone & Joint Institute" #1 collaborator was "Zimmer Biomet" with 2 trials as a collaborator, "American Association of Hip and Knee Surgeons" with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator, "Orthopedic Research and Education Foundation" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Illinois Bone & Joint Institute" are "Rheumatoid Arthritis" (9 trials), "Osteoarthritis" (7 trials), "Arthritis, Rheumatoid" (2 trials), "Low Back Pain" (2 trials) and "Osteoporosis" (2 trials). Many other conditions were trialed in "Illinois Bone & Joint Institute" in a lesser frequency.

Most popular intervention types in "Illinois Bone & Joint Institute" are "Drug" (14 trials), "Device" (9 trials), "Biological" (3 trials), "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Methotrexate" (4 trials), "MM-093" (2 trials), "Ocrelizumab" (2 trials) and "ASR™-XL Modular Acetabular Cup System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Illinois Bone & Joint Institute" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Illinois Bone & Joint Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 16 completed trials in Illinois Bone & Joint Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois Bone & Joint Institute, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".